U.S. regulators on Thursday said transplant recipients and others with significantly weakened immune systems could get additional doses. Pfizer or Moderna COVID-19 vaccine As delta variants...
1 month after controversial approval New Alzheimer’s disease drug, US health regulators approved new prescribing instructions on Thursday that may limit its use. The Food and...
Owosso Memorial Healthcare will soon begin taking the drug. A memorial patient, Bill McKay, was diagnosed with the disease a year ago. McKay and his …...
Vaccine booster shots may help strengthen the defense of some organ transplant recipients against Covid-19. When the pandemic restriction ends, groups that fear suppression of the...
ETSU Health will continue to provide members of the community over the age of 18 with the opportunity to receive one free Janssen Johnson & Johnson...
The US Food and Drug Administration (FDA) has approved a weekly 2.4 mg subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...
Recent Comments